Genomic Health, Inc
|
||
(Name of Issuer)
|
||
Common Stock, par value $0.0001 per share
|
||
(Title of Class of Securities)
|
||
37244C101
|
||
(CUSIP Number)
|
||
Leo Kirby
667 Madison Avenue, 21st Floor
New York, NY 10065
(212) 339-5633
|
||
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
||
March 7, 2011
|
||
(Date of Event which Requires Filing of this Statement)
|
CUSIP No.
|
37244C101
|
Page 2 of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Julian C. Baker
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
|
|
(b) ¨
|
|||
3
|
SEC USE ONLY
|
||
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
41,250
|
8
|
SHARED VOTING POWER
7,571,783
|
|
9
|
SOLE DISPOSITIVE POWER
41,250
|
|
10
|
SHARED DISPOSITIVE POWER
7,571,783
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,613,033
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
26.3%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
CUSIP No.
|
37244C101
|
Page 3 of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Felix J. Baker
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
|
(b) ¨
|
||
3
|
SEC USE ONLY
|
|
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
7,571,783
|
|
9
|
SOLE DISPOSITIVE POWER
0
|
|
10
|
SHARED DISPOSITIVE POWER
7,571,783
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,571,783
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
26.2%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
Item 5.
|
Interest in Securities of the Issuer.
|
Name
|
Number of
Shares
|
Percent of Class
Outstanding
|
||||||
Baker Bros. Investments, L.P.
|
173,897 | 0.6 | % | |||||
Baker Bros. Investments II, L.P.
|
20,287 | 0.1 | % | |||||
667, L.P.
|
1,253,653 | 4.3 | % | |||||
Baker Brothers Life Sciences, L.P.
|
5,603,248 | 19.4 | % | |||||
14159, L.P.
|
152,640 | 0.5 | % | |||||
FBB Associates
|
173,897 | 0.6 | % | |||||
Baker/Tisch Investments, L.P.
|
194,161 | 0.7 | % | |||||
Julian C. Baker
|
41,250 | 0.1 | % | |||||
|
|
|
||||||
Total
|
7,613,033 | 26.3 | % |
|
|
Number of
|
|||||||||
Name
|
Date
|
Shares
|
Transaction
|
Price / Share
|
|||||||
Baker Brothers Life Sciences, L.P.
|
3/4/11
|
9359 |
Purchase
|
25.4961 | |||||||
14159, L.P.
|
3/4/11
|
258 |
Purchase
|
25.4961 | |||||||
Baker Brothers Life Sciences, L.P.
|
3/4/11
|
41,041 |
Purchase
|
25.4435 | |||||||
14159, L.P.
|
3/4/11
|
1,133 |
Purchase
|
25.4435 | |||||||
Baker Brothers Life Sciences, L.P.
|
3/7/11
|
19,463 |
Purchase
|
25.4044 | |||||||
14159, L.P.
|
3/7/11
|
537 |
Purchase
|
25.4044 | |||||||
Baker Brothers Life Sciences, L.P.
|
3/7/11
|
34,592 |
Purchase
|
25.3915 | |||||||
14159, L.P.
|
3/7/11
|
955 |
Purchase
|
25.3915 | |||||||
Baker Brothers Life Sciences, L.P.
|
3/7/11
|
243,285 |
Purchase
|
24.9000 | |||||||
14159, L.P.
|
3/7/11
|
6,715 |
Purchase
|
24.9000 | |||||||
Baker Brothers Life Sciences, L.P.
|
3/8/11
|
1,826 |
Purchase
|
25.1296 | |||||||
14159, L.P.
|
3/8/11
|
50 |
Purchase
|
25.1296 |
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item 7.
|
Material to Be Filed as Exhibits.
|
Exhibit 1.
|
Agreement regarding the joint filing of this statement.
|
By:
|
/s/ Julian C. Baker
|
|
Julian C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix J. Baker
|
By:
|
/s/ Julian C. Baker
|
|
Julian C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix J. Baker
|